Submitted by Anonymous (not verified) on 25 April 2025 - 9:30
Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 2, Status: Authorised